|
Market Closed -
Nasdaq
16:00:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 123.22 USD | -0.92% |
|
-3.72% | +24.75% |
| 08-28 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
| 08-28 | Incyte Partner Knight Seeks Supplemental Approval for Minjuvi Combination in Brazil | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.92% | -3.72% | +3.10% | +28.90% | +24.75% | +43.31% | +90.95% | +61.09% | +51.94% | 25.21B | |
| +0.62% | -3.55% | +4.78% | +33.03% | +3.53% | +38.27% | -3.32% | +18.66% | +103.56% | 79.3B | |
| -0.44% | +1.94% | +34.11% | +77.59% | -0.63% | -19.41% | -36.90% | -44.71% | +55.77% | 59.21B | |
| +1.70% | +1.04% | +156.00% | +204.69% | +375.89% | +480.16% | +24.12% | -62.74% | - | 55.09B | |
| +2.15% | -2.13% | -0.59% | +11.37% | -10.44% | -1.37% | +30.77% | +4.25% | - | 49.86B | |
| -0.55% | -2.14% | -3.41% | -15.30% | -9.77% | +8.08% | +160.02% | +122.23% | +192.49% | 47.9B | |
| -0.85% | -0.67% | +6.75% | +12.70% | +23.10% | +55.16% | -18.97% | -36.07% | -29.11% | 32.28B | |
| -3.44% | +1.37% | +17.82% | +24.54% | +36.13% | +7.18% | +188.73% | +68.92% | - | 23.87B | |
| -3.52% | -0.49% | -4.42% | +3.59% | +35.16% | +58.94% | +112.57% | +139.32% | +344.47% | 16.89B | |
| -3.91% | -3.91% | +43.02% | +8.33% | -11.07% | -8.84% | +773.77% | +492.95% | +7,140.75% | 16.17B | |
| -0.01% | -5.53% | -4.37% | +17.18% | +0.13% | +53.18% | +156.07% | +52.84% | - | 14.97B | |
| +0.87% | +0.25% | +8.68% | +18.54% | +9.76% | +10.39% | -28.62% | -22.54% | -30.53% | 12.52B | |
| -0.25% | -3.35% | -8.93% | -13.78% | +8.69% | +60.78% | +145.69% | +673.05% | +2,641.99% | 10.42B | |
| +2.25% | +5.16% | +5.35% | +20.55% | +45.76% | +141.18% | +188.69% | +520.23% | - | 10.4B | |
| -1.68% | -1.28% | +51.83% | +104.83% | +338.21% | +429.73% | +532.11% | +22.78% | - | 8.87B | |
| -1.19% | -0.49% | -1.32% | +6.78% | -8.11% | -19.14% | -22.25% | -52.48% | -48.23% | 6.91B | |
| -2.06% | +0.73% | +1.52% | +31.85% | +1.26% | -5.48% | +60.30% | -14.74% | - | 6.23B | |
| +0.70% | -0.94% | +5.77% | +62.36% | +90.62% | +129.38% | +356.36% | +525.04% | - | 6.09B | |
| -4.54% | -5.23% | -5.39% | -16.36% | -35.49% | -50.56% | -42.82% | -73.83% | - | 5.71B | |
| +0.07% | -10.60% | +8.18% | -4.14% | +3.69% | +17.43% | +207.16% | +209.16% | - | 5.67B | |
| Average | -0.88% | -1.15% | +15.92% | +30.86% | +46.06% | +71.42% | +143.72% | +130.17% | +1,042.31% | 24.68B | |
| Weighted average by Cap. | -0.46% | -1.83% | +25.65% | +45.06% | +53.93% | +80.69% | +85.45% | +61.66% | +551.45% |
- Stock Market
- Stocks
- INCY Stock
- Sector Incyte Corporation
Select your edition
All financial news and data tailored to specific country editions
